aluates Reports

$ 0.0

Automative

Global Ocular Hypertension Treatment Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-22Z5616

Global Ocular Hypertension Treatment Market Insights Forecast to 2028

BUY CHAPTERS

Global Ocular Hypertension Treatment Market Research Report 2025

Code: QYRE-Auto-22Z5616

Report

June 2025

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Aerie Pharmaceuticals Inc.

Allergan plc

Angelini Group

Chong Kun Dang Pharmaceutical Corp

SALVAT SA

Sophia SA de CV

Lee's Pharmaceutical Holdings Ltd

Neurim Pharmaceuticals Ltd

NicOx SA

Novartis

Ocular Hypertension Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Ocular Hypertension Treatment Market

The global market for Ocular Hypertension Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Ocular hypertension is caused by poor drainage of the fluid inside the eye. Essentially, this means that too much fluid enters the eye without being drained, causing high amount of pressure to build up.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Ocular Hypertension Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Hypertension Treatment.

The Ocular Hypertension Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ocular Hypertension Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ocular Hypertension Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Ocular Hypertension Treatment Market Report

Report Metric	Details
Report Name	Ocular Hypertension Treatment Market
CAGR	5%
Segment by Type	Intraocular Hypertension Glaucoma
Segment by Application	Hospitals Specialty Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Aerie Pharmaceuticals, Inc., Allergan plc, Angelini Group, Chong Kun Dang Pharmaceutical Corp., SALVAT SA, Sophia SA de CV, Lee's Pharmaceutical Holdings Ltd., Neurim Pharmaceuticals Ltd., NicOx SA, Novartis AG
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ocular Hypertension Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Ocular Hypertension Treatment Market report?

Ans: The main players in the Ocular Hypertension Treatment Market are Aerie Pharmaceuticals, Inc., Allergan plc, Angelini Group, Chong Kun Dang Pharmaceutical Corp., SALVAT SA, Sophia SA de CV, Lee's Pharmaceutical Holdings Ltd., Neurim Pharmaceuticals Ltd., NicOx SA, Novartis AG

What are the Application segmentation covered in the Ocular Hypertension Treatment Market report?

Ans: The Applications covered in the Ocular Hypertension Treatment Market report are Hospitals, Specialty Clinics, Others

What are the Type segmentation covered in the Ocular Hypertension Treatment Market report?

Ans: The Types covered in the Ocular Hypertension Treatment Market report are Intraocular Hypertension, Glaucoma

Recommended Reports

Ophthalmic Treatments

Hypertension & Eye Disorders

Ophthalmic Devices & Delivery

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Ocular Hypertension Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Intraocular Hypertension

1.2.3 Glaucoma

1.3 Market by Application

1.3.1 Global Ocular Hypertension Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Specialty Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Ocular Hypertension Treatment Market Perspective (2020-2031)

2.2 Global Ocular Hypertension Treatment Growth Trends by Region

2.2.1 Global Ocular Hypertension Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Ocular Hypertension Treatment Historic Market Size by Region (2020-2025)

2.2.3 Ocular Hypertension Treatment Forecasted Market Size by Region (2026-2031)

2.3 Ocular Hypertension Treatment Market Dynamics

2.3.1 Ocular Hypertension Treatment Industry Trends

2.3.2 Ocular Hypertension Treatment Market Drivers

2.3.3 Ocular Hypertension Treatment Market Challenges

2.3.4 Ocular Hypertension Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Ocular Hypertension Treatment Players by Revenue

3.1.1 Global Top Ocular Hypertension Treatment Players by Revenue (2020-2025)

3.1.2 Global Ocular Hypertension Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Ocular Hypertension Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Ocular Hypertension Treatment Revenue

3.4 Global Ocular Hypertension Treatment Market Concentration Ratio

3.4.1 Global Ocular Hypertension Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Ocular Hypertension Treatment Revenue in 2024

3.5 Global Key Players of Ocular Hypertension Treatment Head office and Area Served

3.6 Global Key Players of Ocular Hypertension Treatment, Product and Application

3.7 Global Key Players of Ocular Hypertension Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Ocular Hypertension Treatment Breakdown Data by Type

4.1 Global Ocular Hypertension Treatment Historic Market Size by Type (2020-2025)

4.2 Global Ocular Hypertension Treatment Forecasted Market Size by Type (2026-2031)

5 Ocular Hypertension Treatment Breakdown Data by Application

5.1 Global Ocular Hypertension Treatment Historic Market Size by Application (2020-2025)

5.2 Global Ocular Hypertension Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Ocular Hypertension Treatment Market Size (2020-2031)

6.2 North America Ocular Hypertension Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Ocular Hypertension Treatment Market Size by Country (2020-2025)

6.4 North America Ocular Hypertension Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Ocular Hypertension Treatment Market Size (2020-2031)

7.2 Europe Ocular Hypertension Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Ocular Hypertension Treatment Market Size by Country (2020-2025)

7.4 Europe Ocular Hypertension Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Ocular Hypertension Treatment Market Size (2020-2031)

8.2 Asia-Pacific Ocular Hypertension Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Ocular Hypertension Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Ocular Hypertension Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Ocular Hypertension Treatment Market Size (2020-2031)

9.2 Latin America Ocular Hypertension Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Ocular Hypertension Treatment Market Size by Country (2020-2025)

9.4 Latin America Ocular Hypertension Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Ocular Hypertension Treatment Market Size (2020-2031)

10.2 Middle East & Africa Ocular Hypertension Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Ocular Hypertension Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Ocular Hypertension Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Aerie Pharmaceuticals, Inc.

11.1.1 Aerie Pharmaceuticals, Inc. Company Details

11.1.2 Aerie Pharmaceuticals, Inc. Business Overview

11.1.3 Aerie Pharmaceuticals, Inc. Ocular Hypertension Treatment Introduction

11.1.4 Aerie Pharmaceuticals, Inc. Revenue in Ocular Hypertension Treatment Business (2020-2025)

11.1.5 Aerie Pharmaceuticals, Inc. Recent Development

11.2 Allergan plc

11.2.1 Allergan plc Company Details

11.2.2 Allergan plc Business Overview

11.2.3 Allergan plc Ocular Hypertension Treatment Introduction

11.2.4 Allergan plc Revenue in Ocular Hypertension Treatment Business (2020-2025)

11.2.5 Allergan plc Recent Development

11.3 Angelini Group

11.3.1 Angelini Group Company Details

11.3.2 Angelini Group Business Overview

11.3.3 Angelini Group Ocular Hypertension Treatment Introduction

11.3.4 Angelini Group Revenue in Ocular Hypertension Treatment Business (2020-2025)

11.3.5 Angelini Group Recent Development

11.4 Chong Kun Dang Pharmaceutical Corp.

11.4.1 Chong Kun Dang Pharmaceutical Corp. Company Details

11.4.2 Chong Kun Dang Pharmaceutical Corp. Business Overview

11.4.3 Chong Kun Dang Pharmaceutical Corp. Ocular Hypertension Treatment Introduction

11.4.4 Chong Kun Dang Pharmaceutical Corp. Revenue in Ocular Hypertension Treatment Business (2020-2025)

11.4.5 Chong Kun Dang Pharmaceutical Corp. Recent Development

11.5 SALVAT SA

11.5.1 SALVAT SA Company Details

11.5.2 SALVAT SA Business Overview

11.5.3 SALVAT SA Ocular Hypertension Treatment Introduction

11.5.4 SALVAT SA Revenue in Ocular Hypertension Treatment Business (2020-2025)

11.5.5 SALVAT SA Recent Development

11.6 Sophia SA de CV

11.6.1 Sophia SA de CV Company Details

11.6.2 Sophia SA de CV Business Overview

11.6.3 Sophia SA de CV Ocular Hypertension Treatment Introduction

11.6.4 Sophia SA de CV Revenue in Ocular Hypertension Treatment Business (2020-2025)

11.6.5 Sophia SA de CV Recent Development

11.7 Lee's Pharmaceutical Holdings Ltd.

11.7.1 Lee's Pharmaceutical Holdings Ltd. Company Details

11.7.2 Lee's Pharmaceutical Holdings Ltd. Business Overview

11.7.3 Lee's Pharmaceutical Holdings Ltd. Ocular Hypertension Treatment Introduction

11.7.4 Lee's Pharmaceutical Holdings Ltd. Revenue in Ocular Hypertension Treatment Business (2020-2025)

11.7.5 Lee's Pharmaceutical Holdings Ltd. Recent Development

11.8 Neurim Pharmaceuticals Ltd.

11.8.1 Neurim Pharmaceuticals Ltd. Company Details

11.8.2 Neurim Pharmaceuticals Ltd. Business Overview

11.8.3 Neurim Pharmaceuticals Ltd. Ocular Hypertension Treatment Introduction

11.8.4 Neurim Pharmaceuticals Ltd. Revenue in Ocular Hypertension Treatment Business (2020-2025)

11.8.5 Neurim Pharmaceuticals Ltd. Recent Development

11.9 NicOx SA

11.9.1 NicOx SA Company Details

11.9.2 NicOx SA Business Overview

11.9.3 NicOx SA Ocular Hypertension Treatment Introduction

11.9.4 NicOx SA Revenue in Ocular Hypertension Treatment Business (2020-2025)

11.9.5 NicOx SA Recent Development

11.10 Novartis AG

11.10.1 Novartis AG Company Details

11.10.2 Novartis AG Business Overview

11.10.3 Novartis AG Ocular Hypertension Treatment Introduction

11.10.4 Novartis AG Revenue in Ocular Hypertension Treatment Business (2020-2025)

11.10.5 Novartis AG Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Aerie Pharmaceuticals Inc.

Allergan plc

Angelini Group

Chong Kun Dang Pharmaceutical Corp

SALVAT SA

Sophia SA de CV

Lee's Pharmaceutical Holdings Ltd

Neurim Pharmaceuticals Ltd

NicOx SA

Novartis

List of Tables

Table 1. Global Ocular Hypertension Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Intraocular Hypertension

Table 3. Key Players of Glaucoma

Table 4. Global Ocular Hypertension Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Ocular Hypertension Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Ocular Hypertension Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Ocular Hypertension Treatment Market Share by Region (2020-2025)

Table 8. Global Ocular Hypertension Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Ocular Hypertension Treatment Market Share by Region (2026-2031)

Table 10. Ocular Hypertension Treatment Market Trends

Table 11. Ocular Hypertension Treatment Market Drivers

Table 12. Ocular Hypertension Treatment Market Challenges

Table 13. Ocular Hypertension Treatment Market Restraints

Table 14. Global Ocular Hypertension Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Ocular Hypertension Treatment Market Share by Players (2020-2025)

Table 16. Global Top Ocular Hypertension Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Hypertension Treatment as of 2024)

Table 17. Ranking of Global Top Ocular Hypertension Treatment Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Ocular Hypertension Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Ocular Hypertension Treatment, Headquarters and Area Served

Table 20. Global Key Players of Ocular Hypertension Treatment, Product and Application

Table 21. Global Key Players of Ocular Hypertension Treatment, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Ocular Hypertension Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Ocular Hypertension Treatment Revenue Market Share by Type (2020-2025)

Table 25. Global Ocular Hypertension Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Ocular Hypertension Treatment Revenue Market Share by Type (2026-2031)

Table 27. Global Ocular Hypertension Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Ocular Hypertension Treatment Revenue Market Share by Application (2020-2025)

Table 29. Global Ocular Hypertension Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Ocular Hypertension Treatment Revenue Market Share by Application (2026-2031)

Table 31. North America Ocular Hypertension Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Ocular Hypertension Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Ocular Hypertension Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Ocular Hypertension Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Ocular Hypertension Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Ocular Hypertension Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Ocular Hypertension Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Ocular Hypertension Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Ocular Hypertension Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Ocular Hypertension Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Ocular Hypertension Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Ocular Hypertension Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Ocular Hypertension Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Ocular Hypertension Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Ocular Hypertension Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Aerie Pharmaceuticals, Inc. Company Details

Table 47. Aerie Pharmaceuticals, Inc. Business Overview

Table 48. Aerie Pharmaceuticals, Inc. Ocular Hypertension Treatment Product

Table 49. Aerie Pharmaceuticals, Inc. Revenue in Ocular Hypertension Treatment Business (2020-2025) & (US$ Million)

Table 50. Aerie Pharmaceuticals, Inc. Recent Development

Table 51. Allergan plc Company Details

Table 52. Allergan plc Business Overview

Table 53. Allergan plc Ocular Hypertension Treatment Product

Table 54. Allergan plc Revenue in Ocular Hypertension Treatment Business (2020-2025) & (US$ Million)

Table 55. Allergan plc Recent Development

Table 56. Angelini Group Company Details

Table 57. Angelini Group Business Overview

Table 58. Angelini Group Ocular Hypertension Treatment Product

Table 59. Angelini Group Revenue in Ocular Hypertension Treatment Business (2020-2025) & (US$ Million)

Table 60. Angelini Group Recent Development

Table 61. Chong Kun Dang Pharmaceutical Corp. Company Details

Table 62. Chong Kun Dang Pharmaceutical Corp. Business Overview

Table 63. Chong Kun Dang Pharmaceutical Corp. Ocular Hypertension Treatment Product

Table 64. Chong Kun Dang Pharmaceutical Corp. Revenue in Ocular Hypertension Treatment Business (2020-2025) & (US$ Million)

Table 65. Chong Kun Dang Pharmaceutical Corp. Recent Development

Table 66. SALVAT SA Company Details

Table 67. SALVAT SA Business Overview

Table 68. SALVAT SA Ocular Hypertension Treatment Product

Table 69. SALVAT SA Revenue in Ocular Hypertension Treatment Business (2020-2025) & (US$ Million)

Table 70. SALVAT SA Recent Development

Table 71. Sophia SA de CV Company Details

Table 72. Sophia SA de CV Business Overview

Table 73. Sophia SA de CV Ocular Hypertension Treatment Product

Table 74. Sophia SA de CV Revenue in Ocular Hypertension Treatment Business (2020-2025) & (US$ Million)

Table 75. Sophia SA de CV Recent Development

Table 76. Lee's Pharmaceutical Holdings Ltd. Company Details

Table 77. Lee's Pharmaceutical Holdings Ltd. Business Overview

Table 78. Lee's Pharmaceutical Holdings Ltd. Ocular Hypertension Treatment Product

Table 79. Lee's Pharmaceutical Holdings Ltd. Revenue in Ocular Hypertension Treatment Business (2020-2025) & (US$ Million)

Table 80. Lee's Pharmaceutical Holdings Ltd. Recent Development

Table 81. Neurim Pharmaceuticals Ltd. Company Details

Table 82. Neurim Pharmaceuticals Ltd. Business Overview

Table 83. Neurim Pharmaceuticals Ltd. Ocular Hypertension Treatment Product

Table 84. Neurim Pharmaceuticals Ltd. Revenue in Ocular Hypertension Treatment Business (2020-2025) & (US$ Million)

Table 85. Neurim Pharmaceuticals Ltd. Recent Development

Table 86. NicOx SA Company Details

Table 87. NicOx SA Business Overview

Table 88. NicOx SA Ocular Hypertension Treatment Product

Table 89. NicOx SA Revenue in Ocular Hypertension Treatment Business (2020-2025) & (US$ Million)

Table 90. NicOx SA Recent Development

Table 91. Novartis AG Company Details

Table 92. Novartis AG Business Overview

Table 93. Novartis AG Ocular Hypertension Treatment Product

Table 94. Novartis AG Revenue in Ocular Hypertension Treatment Business (2020-2025) & (US$ Million)

Table 95. Novartis AG Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Ocular Hypertension Treatment Picture

Figure 2. Global Ocular Hypertension Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Ocular Hypertension Treatment Market Share by Type: 2024 VS 2031

Figure 4. Intraocular Hypertension Features

Figure 5. Glaucoma Features

Figure 6. Global Ocular Hypertension Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Ocular Hypertension Treatment Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Specialty Clinics Case Studies

Figure 10. Others Case Studies

Figure 11. Ocular Hypertension Treatment Report Years Considered

Figure 12. Global Ocular Hypertension Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Ocular Hypertension Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Ocular Hypertension Treatment Market Share by Region: 2024 VS 2031

Figure 15. Global Ocular Hypertension Treatment Market Share by Players in 2024

Figure 16. Global Top Ocular Hypertension Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Hypertension Treatment as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Ocular Hypertension Treatment Revenue in 2024

Figure 18. North America Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Ocular Hypertension Treatment Market Share by Country (2020-2031)

Figure 20. United States Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Ocular Hypertension Treatment Market Share by Country (2020-2031)

Figure 24. Germany Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Ocular Hypertension Treatment Market Share by Region (2020-2031)

Figure 32. China Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Ocular Hypertension Treatment Market Share by Country (2020-2031)

Figure 40. Mexico Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Ocular Hypertension Treatment Market Share by Country (2020-2031)

Figure 44. Turkey Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Ocular Hypertension Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Aerie Pharmaceuticals, Inc. Revenue Growth Rate in Ocular Hypertension Treatment Business (2020-2025)

Figure 48. Allergan plc Revenue Growth Rate in Ocular Hypertension Treatment Business (2020-2025)

Figure 49. Angelini Group Revenue Growth Rate in Ocular Hypertension Treatment Business (2020-2025)

Figure 50. Chong Kun Dang Pharmaceutical Corp. Revenue Growth Rate in Ocular Hypertension Treatment Business (2020-2025)

Figure 51. SALVAT SA Revenue Growth Rate in Ocular Hypertension Treatment Business (2020-2025)

Figure 52. Sophia SA de CV Revenue Growth Rate in Ocular Hypertension Treatment Business (2020-2025)

Figure 53. Lee's Pharmaceutical Holdings Ltd. Revenue Growth Rate in Ocular Hypertension Treatment Business (2020-2025)

Figure 54. Neurim Pharmaceuticals Ltd. Revenue Growth Rate in Ocular Hypertension Treatment Business (2020-2025)

Figure 55. NicOx SA Revenue Growth Rate in Ocular Hypertension Treatment Business (2020-2025)

Figure 56. Novartis AG Revenue Growth Rate in Ocular Hypertension Treatment Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Intraocular Antihypertensive Market Research Report 2025

Hypertension Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Essential Hypertension Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Glaucoma Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Blood Pressure Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ocular Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Eye Disorders Treatments Market Research Report 2024

Global Ocular Tonometry Market Research Report 2024

Portal Hypertension Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antiglaucoma Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hypertension and Heart Failure Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Open Angle Glaucoma Drugs Market Research Report 2024

Global Glaucoma Surgery Products Market Research Report 2024

Ophthalmol Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Keratoconus Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medical Tonometer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Portal Hypertension Market Research Report 2024

Global Anti Fibrotic Therapy for Ocular Fibrosis Market Insights Forecast to 2030

Global Hemianopsia Treatment Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions